Hepion Pharmaceuticals Inc (NASDAQ: HEPA) is -97.96% lower on its value in year-to-date trading and has touched a low of $0.55 and a high of $144.99 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HEPA stock was last observed hovering at around $0.61 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $0.48, the stock is -78.46% and -92.97% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing -21.31% at the moment leaves the stock -98.35% off its SMA200. HEPA registered -99.59% loss for a year compared to 6-month loss of -98.60%. The firm has a 50-day simple moving average (SMA 50) of $6.82822 and a 200-day simple moving average (SMA200) of $29.108555.
The stock witnessed a -93.23% gain in the last 1 month and extending the period to 3 months gives it a -98.08%, and is -39.99% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.52% over the week and 22.44% over the month.
Hepion Pharmaceuticals Inc (HEPA) has around 22 employees, a market worth around $0.52M and $0.00M in sales. Distance from 52-week low is -12.73% and -99.67% from its 52-week high.
.
Hepion Pharmaceuticals Inc (HEPA) Top Institutional Holders
18.0 institutions hold shares in Hepion Pharmaceuticals Inc (HEPA), with institutional investors hold 1.51% of the company’s shares. The shares outstanding are 1.08M, and float is at 1.07M with Short Float at 14.91%. Institutions hold 1.48% of the Float.
Hepion Pharmaceuticals Inc (HEPA) Insider Activity
#####
